Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

TB-Related Articles

Journal Articles Published by Division of TB Elimination (DTBE) Authors

January - December 2009


Amnuaiphon W, Anuwatnonthakate A, Nuyongphak P, Sinthuwatanawibool C, Rujiwongsakorn S, Nakara P, Komsakorn S, Wattanaamornkiet W, Moolphate S, Chiengsorn N, Kaewsaard S, Nateniyom S, Varma JK. Factors associated with death among HIV-uninfected TB patients in Thailand, 2004-2006. Tropical Medicine & International Health 2009 Nov; 14(11):1338-1346.

Asghar RJ, Patlan DE, Miner MC, Rhodes HD, Solages A, Katz D, Beall DS, Ijaz K, Oeltmann JE.  Limited utility of name-based tuberculosis contact investigations among persons using illicit drugs: results of an outbreak investigation. Journal of Public Health: Bulletin of the New York Academy of Medicine. E-pub posted online June 16, 2009.

Bliven E, Podewils L. The role of chronic hepatitis in INH hepatotoxicity during treatment for latent tuberculosis infection. Int J Tuberc Lung Dis 2009; 13:1054-1069.

Buff AM, Sosa LE, Hoopes AJ, Buxton-Morris D, Condren TB, Hadler JL, Haddad MB, Moonan PK, Lobato MN.  Two tuberculosis genotyping clusters, one preventable outbreak.  Public Health Reports 2009; 124: 490-494.

Burman WJ, Bliven EE, Cowan L, Bozeman L, Nahid P, Diem L, et al., for the Tuberculosis Trials Consortium. Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis. Emerg Infect Dis 2009 July.

Cain KP, Anekthananon T, Burapat C, Akksilp S, Mankhatitham W, Srinak C, Nateniyom S, Sattayawuthipong W, Tasaneeyapan T, and Varma JK. Causes of death in HIV-infected persons who have tuberculosis, Thailand. Emerg Infect Dis 2009 Feb. Available online

Chengsorn N, Bloss E, Anekvorapong R, Anuwatnonthakate A, Wattanaamornkiat W, Komsakorn S, Moolphate S, Limsomboon P, Kaewsa-ard S, Nateniyom S, Kanphukiew A, Varma JK. Tuberculosis services and treatment outcomes in private and public health care facilities in Thailand, 2004-2006. Int J Tuberc Lung Dis 2009 July; 13(7): 888-894.

Chideya S, Winston CA, Peloquin CA, Bradford WZ, Hopewell PC, Wells CD, Reingold AL, Kenyon TA, Moeti TL, Tappero JW. Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis 2009 48: 1685-1694.

Cleveland JL, Robison VA, and Panlilio AL. Tuberculosis epidemiology, diagnosis and infection control recommendations for dental settings: an update on the Centers for Disease Control and Prevention guidelines. J Am Dent Assoc 2009; 140: 1092-1099

Cummings KJ, Smith TS, Shogren ES, Khakoo R, Nanda S, Bunner L,Smithmyer A, Soccorsi D, Kashon ML, Mazurek GH, Friedman LN, Weissman DN. Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting. [Concise communication.] Infection Control & Hospital Epidemiology 2009 Nov; 30(11):1123-1126.

Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE, and the Tuberculosis Trials Consortium. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med 2009;180: 273-280.

Dravniece G, Cain KP, Holtz TH, Riekstina V, Leimane V and Zaleskis R. Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis. Eur Respir J 2009 July; 34(1): 180-183.

Frieden TR, Teklehaimanot A, Chideya S, Farmer P, Kim JY, Raviglione MC. A road map to control malaria, tuberculosis, and human immunodeficiency virus/AIDS. Arch Intern Med 2009;169(18):1650-1652.

Heffelfinger JD, Patel P, Brooks JT, Calvet H, Daley CL, Dean HD, Edlin BR, Gensheimer KF, Jereb J, Kent CK, Lennox JL, Louie JK, Lynfield R, Peters PJ, Pinckney L, Spradling P, Voetsch AC, Fiore A. Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis. American Journal of Public Health 2009 Oct; 99(Suppl 2):S333-S339.

Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, Hughes S, Shrestha-Kuwahara R, Sterling TR, Wall K, Weinfurter P, and the Tuberculosis Epidemiologic Studies Consortium. Latent tuberculosis infection treatment acceptance and completion in the United States and Canada. Chest 2009 Nov.

Jittimanee SX, Nateniyom S, Kittikraisak W, Burapat C, Akksilp S, Chumpathat N, Sirinak C, Sattayawuthipong W, Varma JK. Social stigma and knowledge of TB and HIV among patients with both diseases in Thailand. Plos One. 2009;4(7):e6360.

Joesoef MR, Weinstock HS, Kent CK, Chow JM, Boudov MR, Parvez FM, Cox T, Lincoln T, Miller JL, Sternberg M, the Corrections STD Prevalence Monitoring Group. Sex and age correlates of Chlamydia prevalence in adolescents and adults entering correctional facilities, 2005: implications for screening policy. Sexually Transmitted Diseases 2009 Feb; 36(2) supplement, STD, HIV, and Viral Hepatitis in Correctional Facilities:S67-S71.

Kanara N, Cain KP, Chhum V, Eng B, Kim S, Keo S, Heller TA, Varma JK. Association between distance to HIV testing site and uptake of HIV testing for tuberculosis patients in Cambodia. Int J Tuberc Lung Dis 2009 Feb; 13(2): 226-231.

Kapella BK, Anuwatnonthakate A, Komsakorn S, Moolphate S, Charusuntonsri P, Limsomboon P, Wattanaamornkiat W, Nateniyom S, Varma JK. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand. Int J Tuberc Lung Dis 2009 Feb; 13(2): 232-237.

Lam PK, LoBue PA, Catanzaro A. Clinical diagnosis of tuberculosis by specialists and non-specialists. [Notes from the Field.]  Int J Tuberc Lung Dis 2009 May; 13(5):659–661.

Lewinsohn DA, Lobato MN, Jereb JA.  Interferon-[gamma] release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children.  Current Opinion in Pediatrics 2009 Dec. Epub ahead of print.

Lobato MN, Jereb JA, Castro KG.  Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection? [Commentary.]  Pediatrics 2009 Mar; 123(3): 902-903.

LoBue P. Extensively drug-resistant tuberculosis [Review.]. Curr Opin Infect Dis 2009 Apr; 22(2):167-73.

Lönnroth K, Holtz TH, Cobelens F, Chua J, van Leth F, Tupasi T, Williams B. Inclusion of information on risk factors, socio-economic status and health seeking in a tuberculosis prevalence survey. Int J Tuberc Lung Dis 2009 Feb; 13(2):171–176.

Lonnroth L, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol 2009;1–7. Advance Access e-published October 9, 2009 (doi:10.1093/ije/dyp308)

Manangan L, Elmore K, Lewis B, Pratt R, Armstrong L, Davison J, Santibanez S, Heetderks A, Robison V, Lee V, Navin T. Disparities in tuberculosis between Asian/Pacific Islanders and non-Hispanic whites, 1993–2006. Int J Tuberc Lung Dis 2009 Sept; 13 (9):1077-1085.

Marks S. Commentary: Socio-economic determinants of tuberculosis in Recife, Brazil. [Commentary.] International Journal of Epidemiology 2009 Oct; 38(5):1295-1296.

Menzies D, Benedetti A, Paydar A, Royce S, Pai M, Burman W, Vernon A, and Lienhardt C. Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med 2009; 6(9). Online publication posted September 15, 2009.

Menzies D, Benedetti A, Paydar A, Martin I, Royce S, Pai M, Vernon A, Lienhardt C, and Burman W. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med 2009; 6(9). Online publication posted September 15, 2009.

Modi S, Buff AM, Lawson CJ, Rodriguez D, Kirking HL, Lipman H, Fishbein DB.
Reporting patterns and characteristics of tuberculosis among international travelers, United States, June 2006 to May 2008. Clin Infect Dis 2009; 49: 885-891.

Monkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Dung NH, Lan NTN, Yen NTB, Teeratakulpisarn N, Udomsantisuk N, Heilig C, and Varma JK. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med 2009; 180: 903–908.

Mosimaneotsile B, Mathoma A, Chengeta B, Nyirenda S, Agizew T, Tedla Z, Motsamai O, Kilmarx PH, Wells CD, Samandari T.  Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana experience, 2004-2006.  Journal of Acquired Immune Deficiency Syndromes 2009 Nov. Epub ahead of print.

Ngamlert K, Sinthuwattanawibool C, McCarthy KD, Sohn H, Starks A, Kanjanamongkolsiri P, Anek-vorapong R, Tasaneeyapan T, Monkongdee P, Diem L, Varma JK. Diagnostic performance and costs of Capilia TB for Mycobacterium tuberculosis complex identification from broth-based culture in Bangkok, Thailand. Tropical Medicine & International Health 2009 July; 14(7):748-753.

Oeltmann JE, Kammerer JS, Pevzner ES, Moonan PK. Tuberculosis and substance abuse in the United States, 1997-2006. Archives of Internal Medicine 2009; 169(2): 189-197.

Okot-Chono R, Mugisha F, Adatu F, Madraa E, Dlodlo R, Fujiwara P. Health system barriers affecting the implementation of collaborative TB-HIV services in Uganda. Int J Tuberc Lung Dis 2009 Aug;13(8): 955-961.

Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009 Nov 1;49(9):1350-7.

Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 2009 Sept; 13(9):1154-1160.

Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S. Linezolid in the treatment of multidrug-resistant tuberculosis. Clin Infect Dis 2009 Nov 30. [Epub ahead of print].

Shah NS, Lan NTN, Huyen MNT, Laserson K, Iademarco MF, Binkin N, Wells C, Varma JK. Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam. Int J Tuberc Lung Dis 2009 Feb; 13(2): 247-252.

Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, Kebede T, Melaku Z, Mengistu Y, Lemma E, Wells CD, Wuhib T, Nelson LJ. Intensified tuberculosis case finding among HIV-infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr. 2009 Apr 15; 50 (5): 537-45.

Sohn H, Sinthuwattanawibool C, Rienthong S, Varma JK. Fluorescence microscopy is less expensive than Ziehl-Neelsen microscopy in Thailand [Notes from the field]. Int J Tuberc Lung Dis 2009 Feb; 13(2): 266-268.

Starks AM, Gumusboga A, Plikaytis BB, Shinnick TM, Posey JE. Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2009 Mar; 53(3): 1061-6.

Varma JK, Nateniyom S, Akksilp S, Mankatittham W, Sirinak C, Sattayawuthipong W, Burapat C, Kittikraisak W, Monkongdee P, Cain KP, Wells CD, Tappero JW. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis 2009 Apr 13;9:42.

Vitek E, Gusseinova N, Laricheva N, Vasiliev S, Molotilov V, Sofronova R, Kazionny B, Cegielski P, Nguyen ML, Nelson L, Agerton T, Wells C. Factors associated with positive tuberculin skin test results among HIV-infected persons in Orel Oblast, Russia. Int J Tuberc Lung Dis 2009 July; 13(7): 829-835.

Wallace RM, Kammerer JS, Iademarco MF, Althomsons SP, Winston CA, and Navin TR.  Increasing proportions of advanced pulmonary tuberculosis reported in the United States: are delays in diagnosis on the rise?  Am J Respir Crit Care Med  2009; 180: 1016-1022.

Wang S-H, Pancholi P, Stevenson K, Yakrus MA, Butler WR, Schlesinger LS, Mangino JE. Pseudo-outbreak of "Mycobacterium paraffinicum" infection and/or colonization in a tertiary care medical center. Infection Control & Hospital Epidemiology 2009 Sept; 30(9): 848-853.

Zaunbrecher MA, Sikes D, Metchock B, Shinnick TM, Posey JE. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.  Proc Natl Acad Sci USA 2009; 106(47):  20004-9.
 
Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #